COMP <GO>
RDW vs TMO // FORWARD P/E MULTIPLE
Redwire Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RDW 3
— TMO 11
▲ FORWARD P/E MULTIPLE LEADER: RDW
LAST: $8.39 (-8.41%) • MKT CAP: $2.29B
forward-pe
31.0x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 5.20% | 41.00% | -35.80 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -17.40% | 9.30% | -26.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.33% | 2.40% | -10.73 | TMO | /fcf-yield <GO> |
| Operating Margin | -60.00% | 17.40% | -77.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 15.10% | -75.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 10.30% | 3.90% | +6.40 | RDW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.59 | 4.50 | -0.91 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 59.1 | -20.42 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.94 | +0.05 | RDW | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 31.0x | 36.3x | -5.30 | RDW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.29B | $262.22B | -$259.93B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDW REV | TMO REV | RDW GROSS % | TMO GROSS % | RDW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $335.4M | $44.56B | 5.2% | 44.0% | -$190.8M | $6.29B |
| FY 2024 | $304.1M | $42.88B | 14.6% | 44.0% | -$23.7M | $7.27B |
| FY 2023 | $243.8M | $42.86B | 44.0% | 44.0% | -$9.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDW // BETA 0.99
TMO // BETA 0.94